Journal of Pharmaceutical Sciences & Emerging DrugsISSN: 2380-9477

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Perspective, J Pharm Sci Emerg Drugs Vol: 11 Issue: 3

Pediatric Pharmaceutical Formulation: Addressing Challenges in Medication Administration to Children

Bingjie Chun*

1School of Pharmaceutical Sciences, Ts inghua University, Beijing, China

*Corresponding Author: Bingjie Chun,
School of Pharmaceutical Sciences, Tsinghua University, Beijing, China
E-mail: chungb@tsinghua.edu.cn

Received date: 22 May, 2023, Manuscript No. JPSED-23-106501;

Editor assigned date: 24 May, 2023, Pre QC. JPSED-23-106501 (PQ);

Reviewed date: 15 June, 2023, QC No. JPSED-23-106501;

Revised date: 22 June, 2023, Manuscript No. JPSED-23-106501 (R);

Published date: 29 June, 2023, DOI: 10.4172/2380-9477.1000143.

Citation: Chun B (2023) Pediatric Pharmaceutical Formulation: Addressing Challenges in Medication Administration to Children. J Pharm Sci Emerg Drugs 11:3.

Abstract

Pediatric patients pose unique challenges when it comes to medication administration. Children have specific physiological and developmental characteristics that necessitate tailored pharmaceutical formulations. This study explores the importance of pediatric pharmaceutical formulation and the challenges associated with medication administration to children. It delves into strategies and advancements in the field to overcome these challenges and ensure safe and effective medication delivery to pediatric populations.

Keywords: Pediatric Pharmaceutical

Description

Pediatric patients pose unique challenges when it comes to medication administration. Children have specific physiological and developmental characteristics that necessitate tailored pharmaceutical formulations. This study explores the importance of pediatric pharmaceutical formulation and the challenges associated with medication administration to children. It delves into strategies and advancements in the field to overcome these challenges and ensure safe and effective medication delivery to pediatric populations.

Physiological and developmental considerations

Pediatric patients undergo rapid growth and development, which affects their pharmacokinetics and pharmacodynamics. Factors such as gastric pH, gastrointestinal motility, liver function, and renal clearance differ from those of adults, influencing drug absorption, distribution, metabolism, and excretion. Moreover, children often have difficulty swallowing tablets or capsules and may require age-appropriate formulations to ensure proper administration.

Challenges in medication administration

Medication administration to children can be challenging due to factors such as taste aversion, limited swallowing ability, and dosage accuracy. Pediatric patients may resist taking medications due to unpleasant tastes or textures, leading to non-compliance. Furthermore, obtaining accurate dosages for pediatric formulations can be challenging, as weight-based or body surface area calculations are often often necessary. Over- or under-dosing can have significant consequences on therapeutic outcomes and safety.

Strategies in pediatric pharmaceutical formulation

To address the challenges in pediatric medication administration, several strategies have been employed in pharmaceutical formulation. Liquid formulations, including solutions, suspensions, and syrups, are commonly used for ease of administration and dose flexibility. Flavoring agents are added to enhance palatability and increase acceptance by children. Effervescent tablets or orally disintegrating formulations are designed to dissolve or disintegrate quickly in the mouth, facilitating administration to children who have difficulty swallowing solid dosage forms.

Modified-release formulations offer advantages for drugs requiring prolonged or controlled release profiles. These formulations can reduce the frequency of administration and maintain therapeutic drug levels over an extended period. However, careful consideration of ageappropriate dosage forms and individual patient characteristics is essential to ensure optimal therapeutic outcomes and safety.

Innovative technologies, such as mini-tablets, chewable tablets, films, and oral powders, have emerged to address pediatric medication administration challenges. Mini-tablets allow for flexible dosing and are easier to swallow compared to standard-sized tablets. Chewable tablets provide a palatable option for children, while orally dissolving films offer convenient administration without the need for water. Powders that can be reconstituted into a liquid form provide dose flexibility and ease of administration.

Pediatric-specific dosage forms, such as pediatric oral syringes with clear markings for accurate dosing, have gained prominence to enhance medication safety. Additionally, child-resistant packaging is essential to prevent accidental ingestion and ensure medication security.

Conclusion

Pediatric pharmaceutical formulation plays an acute role in addressing challenges in medication administration to children. Consideration of physiological and developmental factors is a key when developing age-appropriate formulations. Strategies such as liquid formulations, modified-release technologies, innovative dosage forms, and appropriate packaging can enhance medication acceptance, accuracy, and safety. Ongoing research and collaboration between pharmaceutical companies, healthcare professionals, and regulatory bodies are essential to continue improving pediatric pharmaceutical formulations, ensuring optimal therapeutic outcomes and promoting the well-being of pediatric patients. By addressing these challenges, we can enhance medication adherence and improve health outcomes for children in need of pharmacotherapy.

international publisher, scitechnol, subscription journals, subscription, international, publisher, science

Track Your Manuscript

Awards Nomination